Fulcrum Therapeutics, Inc. - COM (FULC)

Historical Portfolio Holders from Q3 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
54.7M
Holdings value Q3 2024
$195M
Value change Q3 2024
-$86.9M
Grand Portfolio weight change Q3 2024
0%
Number of holders
125
Number of buys Q3 2024
70
Number of sells Q3 2024
-70
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 54.7M $195M -$86.9M $3.57 130
2024 Q2 64.8M $401M +$19.7M $6.20 124
2024 Q1 60.3M $570M -$2.97M $9.44 122
2023 Q4 61.1M $412M +$14M $6.75 99
2023 Q3 56.4M $250M +$9.02M $4.44 80
2023 Q2 55.5M $183M -$14.2M $3.30 86
2023 Q1 60.4M $172M +$51.6K $2.85 116
2022 Q4 50.6M $368M -$13.1M $7.28 109
2022 Q3 52.2M $422M +$98.7M $8.09 103
2022 Q2 40.1M $197M -$32.7M $4.90 100
2022 Q1 39.1M $924M +$64.7M $23.65 106
2021 Q4 37.2M $657M -$42.8M $17.69 109
2021 Q3 36.6M $1.03B +$305M $28.21 102
2021 Q2 26.8M $281M -$3.28M $10.48 66
2021 Q1 26.9M $317M +$45.6M $11.78 68
2020 Q4 22.2M $260M +$20.2M $11.71 65
2020 Q3 20.6M $163M -$36.9M $7.93 53
2020 Q2 20.5M $374M +$66.4M $18.29 60
2020 Q1 16.8M $201M +$11.9M $11.94 46
2019 Q4 15.8M $262M +$1.37M $16.64 38
2019 Q3 15.9M $105M +$105M $6.64 39